The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biopharmaceuticals Market Research Report 2024
Synopsis
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
The global Biopharmaceuticals market was valued at US$ 32400 million in 2023 and is anticipated to reach US$ 55880 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
North American market for Biopharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biopharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biopharmaceuticals in Tumor is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biopharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals.
Report Scope
The Biopharmaceuticals market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
SANDOZ (NOVARTIS)
Teva Pharmaceutical
Hospira （Pfizer）
MYLAN
Sun pharma
Segment by Type
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Segment by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceuticals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
The global Biopharmaceuticals market was valued at US$ 32400 million in 2023 and is anticipated to reach US$ 55880 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
North American market for Biopharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biopharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biopharmaceuticals in Tumor is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biopharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals.
Report Scope
The Biopharmaceuticals market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
SANDOZ (NOVARTIS)
Teva Pharmaceutical
Hospira （Pfizer）
MYLAN
Sun pharma
Segment by Type
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Segment by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceuticals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceuticals Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Colony-Stimulating Factor
1.2.5 Erythropoietin
1.2.6 Insulin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biopharmaceuticals Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceuticals Market Perspective (2019-2030)
2.2 Biopharmaceuticals Growth Trends by Region
2.2.1 Global Biopharmaceuticals Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biopharmaceuticals Historic Market Size by Region (2019-2024)
2.2.3 Biopharmaceuticals Forecasted Market Size by Region (2025-2030)
2.3 Biopharmaceuticals Market Dynamics
2.3.1 Biopharmaceuticals Industry Trends
2.3.2 Biopharmaceuticals Market Drivers
2.3.3 Biopharmaceuticals Market Challenges
2.3.4 Biopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceuticals Players by Revenue
3.1.1 Global Top Biopharmaceuticals Players by Revenue (2019-2024)
3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2019-2024)
3.2 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceuticals Revenue
3.4 Global Biopharmaceuticals Market Concentration Ratio
3.4.1 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceuticals Revenue in 2023
3.5 Biopharmaceuticals Key Players Head office and Area Served
3.6 Key Players Biopharmaceuticals Product Solution and Service
3.7 Date of Enter into Biopharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceuticals Breakdown Data by Type
4.1 Global Biopharmaceuticals Historic Market Size by Type (2019-2024)
4.2 Global Biopharmaceuticals Forecasted Market Size by Type (2025-2030)
5 Biopharmaceuticals Breakdown Data by Application
5.1 Global Biopharmaceuticals Historic Market Size by Application (2019-2024)
5.2 Global Biopharmaceuticals Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biopharmaceuticals Market Size (2019-2030)
6.2 North America Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biopharmaceuticals Market Size by Country (2019-2024)
6.4 North America Biopharmaceuticals Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceuticals Market Size (2019-2030)
7.2 Europe Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biopharmaceuticals Market Size by Country (2019-2024)
7.4 Europe Biopharmaceuticals Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceuticals Market Size (2019-2030)
8.2 Asia-Pacific Biopharmaceuticals Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biopharmaceuticals Market Size by Region (2019-2024)
8.4 Asia-Pacific Biopharmaceuticals Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceuticals Market Size (2019-2030)
9.2 Latin America Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biopharmaceuticals Market Size by Country (2019-2024)
9.4 Latin America Biopharmaceuticals Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceuticals Market Size (2019-2030)
10.2 Middle East & Africa Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biopharmaceuticals Market Size by Country (2019-2024)
10.4 Middle East & Africa Biopharmaceuticals Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Biopharmaceuticals Introduction
11.1.4 Roche Revenue in Biopharmaceuticals Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Biopharmaceuticals Introduction
11.2.4 Amgen Revenue in Biopharmaceuticals Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biopharmaceuticals Introduction
11.3.4 AbbVie Revenue in Biopharmaceuticals Business (2019-2024)
11.3.5 AbbVie Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Detail
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Biopharmaceuticals Introduction
11.4.4 Sanofi-Aventis Revenue in Biopharmaceuticals Business (2019-2024)
11.4.5 Sanofi-Aventis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Biopharmaceuticals Introduction
11.5.4 Johnson & Johnson Revenue in Biopharmaceuticals Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biopharmaceuticals Introduction
11.6.4 Pfizer Revenue in Biopharmaceuticals Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Detail
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biopharmaceuticals Introduction
11.7.4 Novo Nordisk Revenue in Biopharmaceuticals Business (2019-2024)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biopharmaceuticals Introduction
11.8.4 Eli Lilly Revenue in Biopharmaceuticals Business (2019-2024)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Biopharmaceuticals Introduction
11.9.4 Novartis Revenue in Biopharmaceuticals Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Biopharmaceuticals Introduction
11.10.4 Merck Revenue in Biopharmaceuticals Business (2019-2024)
11.10.5 Merck Recent Development
11.11 Sun
11.11.1 Sun Company Detail
11.11.2 Sun Business Overview
11.11.3 Sun Biopharmaceuticals Introduction
11.11.4 Sun Revenue in Biopharmaceuticals Business (2019-2024)
11.11.5 Sun Recent Development
11.12 3sbio
11.12.1 3sbio Company Detail
11.12.2 3sbio Business Overview
11.12.3 3sbio Biopharmaceuticals Introduction
11.12.4 3sbio Revenue in Biopharmaceuticals Business (2019-2024)
11.12.5 3sbio Recent Development
11.13 Changchun High Tech
11.13.1 Changchun High Tech Company Detail
11.13.2 Changchun High Tech Business Overview
11.13.3 Changchun High Tech Biopharmaceuticals Introduction
11.13.4 Changchun High Tech Revenue in Biopharmaceuticals Business (2019-2024)
11.13.5 Changchun High Tech Recent Development
11.14 CP Guojian
11.14.1 CP Guojian Company Detail
11.14.2 CP Guojian Business Overview
11.14.3 CP Guojian Biopharmaceuticals Introduction
11.14.4 CP Guojian Revenue in Biopharmaceuticals Business (2019-2024)
11.14.5 CP Guojian Recent Development
11.15 Biotech
11.15.1 Biotech Company Detail
11.15.2 Biotech Business Overview
11.15.3 Biotech Biopharmaceuticals Introduction
11.15.4 Biotech Revenue in Biopharmaceuticals Business (2019-2024)
11.15.5 Biotech Recent Development
11.16 Gelgen
11.16.1 Gelgen Company Detail
11.16.2 Gelgen Business Overview
11.16.3 Gelgen Biopharmaceuticals Introduction
11.16.4 Gelgen Revenue in Biopharmaceuticals Business (2019-2024)
11.16.5 Gelgen Recent Development
11.17 Innovent
11.17.1 Innovent Company Detail
11.17.2 Innovent Business Overview
11.17.3 Innovent Biopharmaceuticals Introduction
11.17.4 Innovent Revenue in Biopharmaceuticals Business (2019-2024)
11.17.5 Innovent Recent Development
11.18 Dong Bao
11.18.1 Dong Bao Company Detail
11.18.2 Dong Bao Business Overview
11.18.3 Dong Bao Biopharmaceuticals Introduction
11.18.4 Dong Bao Revenue in Biopharmaceuticals Business (2019-2024)
11.18.5 Dong Bao Recent Development
11.19 Ganlee
11.19.1 Ganlee Company Detail
11.19.2 Ganlee Business Overview
11.19.3 Ganlee Biopharmaceuticals Introduction
11.19.4 Ganlee Revenue in Biopharmaceuticals Business (2019-2024)
11.19.5 Ganlee Recent Development
11.20 United Laboratories
11.20.1 United Laboratories Company Detail
11.20.2 United Laboratories Business Overview
11.20.3 United Laboratories Biopharmaceuticals Introduction
11.20.4 United Laboratories Revenue in Biopharmaceuticals Business (2019-2024)
11.20.5 United Laboratories Recent Development
11.21 SANDOZ (NOVARTIS)
11.21.1 SANDOZ (NOVARTIS) Company Detail
11.21.2 SANDOZ (NOVARTIS) Business Overview
11.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Introduction
11.21.4 SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2019-2024)
11.21.5 SANDOZ (NOVARTIS) Recent Development
11.22 Teva Pharmaceutical
11.22.1 Teva Pharmaceutical Company Detail
11.22.2 Teva Pharmaceutical Business Overview
11.22.3 Teva Pharmaceutical Biopharmaceuticals Introduction
11.22.4 Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2019-2024)
11.22.5 Teva Pharmaceutical Recent Development
11.23 Hospira （Pfizer）
11.23.1 Hospira （Pfizer） Company Detail
11.23.2 Hospira （Pfizer） Business Overview
11.23.3 Hospira （Pfizer） Biopharmaceuticals Introduction
11.23.4 Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2019-2024)
11.23.5 Hospira （Pfizer） Recent Development
11.24 MYLAN
11.24.1 MYLAN Company Detail
11.24.2 MYLAN Business Overview
11.24.3 MYLAN Biopharmaceuticals Introduction
11.24.4 MYLAN Revenue in Biopharmaceuticals Business (2019-2024)
11.24.5 MYLAN Recent Development
11.25 Sun pharma
11.25.1 Sun pharma Company Detail
11.25.2 Sun pharma Business Overview
11.25.3 Sun pharma Biopharmaceuticals Introduction
11.25.4 Sun pharma Revenue in Biopharmaceuticals Business (2019-2024)
11.25.5 Sun pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
